Toronto Dominion Bank
ASND icon

Toronto Dominion Bank’s Ascendis Pharma A/S ASND Stock Holding History

Toronto Dominion Bank’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7M Sell
11,800
-7,500
-39% -$1.68M ﹤0.01% 1049
2025
Q4 		$4.09M Buy
+19,300
New +$3.99M 0.01% 907

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Toronto Dominion Bank's ASND Position: Q4 2025 in Review

Toronto Dominion Bank sold out of Ascendis Pharma A/S (ASND) in Q4 2025, closing a stake of 1,646 shares — an estimated $340K sold.

Toronto Dominion Bank first reported a position in ASND in Q3 2025 and held it in 1 quarter. The position peaked at $327K in Q3 2025. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

  • Toronto Dominion Bank reported no remaining Ascendis Pharma A/S position as of Q4 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 1,646 Ascendis Pharma A/S shares in Q4 2025, an estimated $340K.
  • Toronto Dominion Bank first reported a position in Ascendis Pharma A/S in Q3 2025 and held it in 1 quarter.
  • Toronto Dominion Bank's Ascendis Pharma A/S position peaked at $327K in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.